Imperial College London


Faculty of MedicineDepartment of Immunology and Inflammation

Professor of Haemato-oncology



+44 (0)20 3313 3237j.apperley




Miss Mandy Sale +44 (0)20 3313 4017




4N3CHammersmith HospitalHammersmith Campus






Innes AJ, Mullish BH, Ghani R, et al., 2021, Fecal microbiota transplant mitigates adverse outcomes in patients colonized with multidrug-resistant organisms undergoing allogeneic hematopoietic cell transplantation, Frontiers in Cellular and Infection Microbiology, ISSN:2235-2988

Rea D, Mauro MJ, Boquimpani C, et al., 2021, A phase 3, open-label, randomized study of asciminib, a STAMP inhibitor, vs bosutinib in CML after ≥2 prior TKIs, Blood, ISSN:0006-4971

Cortes J, Apperley JF, Lomaia E, et al., 2021, Ponatinib Dose-Ranging Study in Chronic-Phase Chronic Myeloid Leukemia: A Randomized, Open-Label Phase 2 Clinical Trial., Blood

Ljungman P, de la Camara R, Mikulska M, et al., 2021, COVID-19 and stem cell transplantation; results from an EBMT and GETH multicenter prospective survey, Leukemia, ISSN:0887-6924

Lawless S, Sbianchi G, Morris C, et al., 2021, IgD Subtype But Not IgM or Non-Secretory Is a Prognostic Marker for Poor Survival Following Autologous Hematopoietic Cell Transplantation in Multiple Myeloma. Results From the EBMT CALM (Collaboration to Collect Autologous Transplant Outcomes in Lymphomas and Myeloma) Study., Clin Lymphoma Myeloma Leuk

More Publications